Baxter
BAX
26,07 €
Share price
3.42%
Change (1 day)
-31.96%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Revenue for Baxter (BAX)
Revenue in 2024 (TTM): €11.94 Billion
According to Baxter's latest financial reports the company's current revenue (TTM 
) is €11.32 Billion. a decrease over the revenue in the year 2023 that were of €12.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Baxter from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €12.35 B | -0.34% |
| 2023 | €12.39 B | -10.13% |
| 2022 | €13.79 B | 22.2% |
| 2021 | €11.28 B | 18.95% |
| 2020 | €9.49 B | -6.43% |
| 2019 | €10.14 B | 4.33% |
| 2018 | €9.72 B | 10.44% |
| 2017 | €8.80 B | -8.9% |
| 2016 | €9.66 B | 5.98% |
| 2015 | €9.11 B | -26.97% |
| 2014 | €12.48 B | 13.46% |
| 2013 | €11.00 B | 2.57% |
| 2012 | €10.72 B | 0.28% |
| 2011 | €10.69 B | 10.8% |
| 2010 | €9.65 B | 10.12% |
| 2009 | €8.76 B | -0.73% |
| 2008 | €8.83 B | 14.5% |
| 2007 | €7.71 B | -1.92% |
| 2006 | €7.86 B | -5.4% |
| 2005 | €8.31 B | 18.61% |
| 2004 | €7.00 B | -1% |
| 2003 | €7.08 B | -7.88% |
| 2002 | €7.68 B | -11.42% |
| 2001 | €8.67 B | 18.53% |
| 2000 | €7.32 B | 15.46% |
| 1999 | €6.34 B | 22.34% |
| 1998 | €5.18 B | 0.2% |
| 1997 | €5.17 B | 12.87% |
| 1996 | €4.58 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €195.67 B | 1,628.06% | 🇺🇸 USA |
 | €19.90 B | 75.75% | 🇺🇸 USA |
 | €14.74 B | 30.26% | 🇺🇸 USA |
 | €18.17 B | 60.55% | 🇺🇸 USA |
 | €0.89 B | -92.10% | 🇺🇸 USA |
 | €37.76 B | 233.53% | 🇺🇸 USA |
 | €0.26 B | -97.68% | 🇺🇸 USA |
 | €9.42 B | -16.76% | 🇺🇸 USA |
 | €29.24 B | 158.24% | 🇮🇪 Ireland |
 | €2.09 B | -81.47% | 🇺🇸 USA |